Aug 11, 2010
SANTA MONICA, Calif., Aug. 11 /PRNewswire-FirstCall/ -- Derycz Scientific, Inc. (OTC Bulletin Board: DYSC), a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, today announced that its subsidiary, Reprints Desk, has secured an exclusive, multi-year contract to provide article reprints and ePrints services for the Journal of the American Medical Association (JAMA), the nine specialty Archives Journals published by the American Medical Association (AMA), American Medical News, and Disaster Medicine and Public Health Preparedness (DMPHP). Life science companies and others use reprints and ePrints—bulk copies of physically reproduced or digitally deployed copyrighted materials—as educational tools for communicating with healthcare professionals and consumers.
The multi-year agreement went into effect on July 27, 2010. Under the terms of the agreement, the reprints and ePrints services that Reprints Desk will provide will include article quoting and order processing, printing, delivery and deployment, billing, and customer satisfaction. Financial details were not disclosed.
"Derycz Scientific is honored that Reprints Desk has been selected as the sole supplier entrusted with managing reprints for JAMA and other AMA journals that are respected worldwide for their excellence, integrity and leadership," said Peter Derycz, President and Chief Executive Officer of Derycz Scientific. "As an organization that believes that science improves public health, Derycz Scientific is committed to making it easier for professionals in the life sciences and supporting industries to locate, license and re-use this important content that ultimately saves and improves lives."
"We at the American Medical Association are impressed with Reprints Desk's initiatives and its abilities to manage the reprint and eprint business issues that arise in the handling of published materials," said Elizabeth Jones, Sr. VP of Periodical Publishing. "We can think of no better company to oversee the smooth running of these varieties of services for our flagship publication, JAMA, as well as our other marquis journals."
About Derycz Scientific®
Derycz Scientific, Inc. (the "Company") develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk and Pools Press. Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprint Desk is an innovator in content retrieval and ePrint delivery and its services are designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for over 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces, newsletters, and all business stationery; and works with publishers who wish to outsource a portion of or all of their reprints business. For more information, go to www.deryczscientific.com.
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. The Company assumes no obligation to update the information in this release.
SOURCE Derycz Scientific, Inc.